Pharmacokinetics of Vandetanib in Subjects with Renal or Hepatic Impairment

被引：0
|
作者：
Angelika Weil
Paul Martin
Robert Smith
Stuart Oliver
Peter Langmuir
Jessica Read
Karl-Heinz Molz
机构：
[1] APEX GmbH,
[2] Astra Zeneca,undefined
来源：
Clinical Pharmacokinetics | 2010年 / 49卷
关键词：
Renal Impairment; Normal Renal Function; Hepatic Impairment; Plasma Protein Binding; Severe Renal Impairment;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：607 / 618
页数：11
相关论文
共 50 条
  • [1] Pharmacokinetics of Vandetanib in Subjects with Renal or Hepatic Impairment
    Weil, Angelika
    Martin, Paul
    Smith, Robert
    Oliver, Stuart
    Langmuir, Peter
    Read, Jessica
    Molz, Karl-Heinz
    [J]. CLINICAL PHARMACOKINETICS, 2010, 49 (09) : 607 - 618
  • [2] Pharmacokinetics of Tedizolid in Subjects with Renal or Hepatic Impairment
    Flanagan, S.
    Minassian, S. L.
    Morris, D.
    Ponnuraj, R.
    Marbury, T. C.
    Alcorn, H. W.
    Fang, E.
    Prokocimer, P.
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2014, 58 (11) : 6471 - 6476
  • [3] Pharmacokinetics and Safety of Momelotinib in Subjects With Hepatic or Renal Impairment
    Xin, Yan
    Kawashima, Jun
    Weng, Winnie
    Kwan, Ellen
    Tarnowski, Thomas
    Silverman, Jeffrey A.
    [J]. JOURNAL OF CLINICAL PHARMACOLOGY, 2018, 58 (04): : 522 - 532
  • [4] Pharmacokinetics of Intravenous Conivaptan in Subjects With Hepatic or Renal Impairment
    Roy, Michael J.
    Erdman, Keith A.
    Abeyratne, Anura T.
    Plumb, Lisa C.
    Lasseter, Kenneth
    Riff, Dennis S.
    Keirns, James J.
    [J]. CLINICAL PHARMACOKINETICS, 2013, 52 (05) : 385 - 395
  • [5] Pharmacokinetics of insulin detemir in subjects with renal or hepatic impairment
    Jacobsen, LV
    Popescu, G
    Plum, A
    [J]. DIABETES, 2002, 51 : A102 - A102
  • [6] Pharmacokinetics of Intravenous Conivaptan in Subjects With Hepatic or Renal Impairment
    Michael J. Roy
    Keith A. Erdman
    Anura T. Abeyratne
    Lisa C. Plumb
    Kenneth Lasseter
    Dennis S. Riff
    James J. Keirns
    [J]. Clinical Pharmacokinetics, 2013, 52 : 385 - 395
  • [7] Pharmacokinetics of insulin detemir in subjects with renal or hepatic impairment.
    Jacobsen, LV
    Popescu, G
    Plum, A
    [J]. DIABETOLOGIA, 2002, 45 : A259 - A260
  • [8] Single-dose pharmacokinetics of quetiapine in subjects with renal or hepatic impairment
    Thyrum, PT
    Wong, YWJ
    Yeh, C
    [J]. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY, 2000, 24 (04): : 521 - 533
  • [9] Pharmacokinetics of escitalopram in subjects with hepatic impairment
    Areberg, J
    Christophersen, JS
    Poulsen, MN
    Larsen, F
    [J]. NORDIC JOURNAL OF PSYCHIATRY, 2005, 59 (05) : 406 - 406
  • [10] Pharmacokinetics Of Nintedanib In Subjects With Hepatic Impairment
    Marzin, K.
    Kretschmar, G.
    Schlenker-Herceg, R.
    Dallinger, C.
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2017, 195
12345